Neurological outcomes for patients meeting radiographic criteria for DEFUSE 3 and SELECT2.

Rahul R KaramchandaniSagar SatyanarayanaHongmei YangDale StrongJeremy RhotenJonathan ClementeGary DefilippNikhil M PatelJoe BernardWilliam StetlerJonathan M ParishGregory W AlbersNicholas J LeeperAmy K GuzikStacey Quintero WolfeAndrew HinesHarsh N PatelAnna Maria HelmsLauren MackoLaura WilliamsJulia RetelskiAndrew W Asimos

Published in: Journal of neurointerventional surgery (2024)

Nearly half of patients meeting radiographic criteria common to DEFUSE 3 and SELECT2 are functionally independent at 90 days, similar to rates reported for the treated DEFUSE 3 cohort. This might be due to their moderate core volumes and large ischemic penumbra.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
metabolic syndrome
adipose tissue
ischemia reperfusion injury
glycemic control